Your session is about to expire
← Back to Search
Neuromodulation Device
De Novo group for Sacral Neuromodulation
N/A
Waitlist Available
Research Sponsored by Axonics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Summary
A prospective, multi-center, study comparing continuous sacral neuromodulation (SNM) stimulation to daily cyclic stimulation of 2 hours "on" and 22 hours "off" using the Axonics System.
Eligible Conditions
- Sacral Neuromodulation
- Urge Incontinence
- Overactive Bladder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To evaluate the efficacy of daily cyclic stimulation of 2 hours "on" and 22 hours "off" in reducing UUI episodes by > 50% in newly implanted participants, or maintenance of efficacy in currently implanted participants with an implanted Axonics System
Secondary outcome measures
To evaluate patient satisfaction with cyclic stimulation
Trial Design
2Treatment groups
Experimental Treatment
Group I: Implanted groupExperimental Treatment1 Intervention
This group will be participants with urinary urge incontinence (UUI) who have been previously implanted with an Axonics System and are satisfied with therapy
Group II: De Novo groupExperimental Treatment1 Intervention
This group will be participants who are newly implanted with an Axonics System.
Find a Location
Who is running the clinical trial?
Axonics, Inc.Lead Sponsor
4 Previous Clinical Trials
578 Total Patients Enrolled
Axonics Modulation Technologies, Inc.Lead Sponsor
3 Previous Clinical Trials
468 Total Patients Enrolled
Karen Noblett, MDStudy DirectorAxonics, Inc.
8 Previous Clinical Trials
680 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger